Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor

Laryngoscope

Volumn 122, Issue 7, 2012, Pages 1539-1544

  Sweeny, Larissa ^a   Liu, Zhiyong ^a   Lancaster, William ^b   Hart, Justin ^a   Hartman, Yolanda E ^a   Rosenthal, Eben L ^a  

^a University of Alabama at Birmingham   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

fibroblast growth factor receptor; Head and neck squamous cell carcinoma; stroma fibroblast

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; FIBROBLAST GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FIBROBLAST; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; NICK END LABELING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; FIBROBLASTS; HEAD AND NECK NEOPLASMS; HUMANS; MICE; PYRIMIDINES; RECEPTORS, FIBROBLAST GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 84862866921     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23266     Document Type: Article

References (15)

1. Bhowmick NA, Neilson EG, Moses HL,. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-337.
2. Acevedo VD, Ittmann M, Spencer DM,. Paths of FGFR-driven tumorigenesis. Cell Cycle 2009; 8: 580-588.
3. Lamont FR, Tomlinson DC, Cooper PA, Shnyder SD, Chester JD, Knowles MA,. Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo. Br J Cancer 2011; 104: 75-82.
4. Hase T, Kawashiri S, Tanaka A, et al. Correlation of basic fibroblast growth factor expression with the invasion and the prognosis of oral squamous cell carcinoma. J Oral Pathol Med 2006; 35: 136-139.
5. Freier K, Schwaenen C, Sticht C, et al. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Oral Oncol 2007; 43: 60-66.
6. Marshall ME, Hinz TK, Kono SA, et al. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells. Clin Cancer Res 2011; 17: 5016-5025.
7. Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP,. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 573-579.
8. Drugan CS, Paterson IC, Prime SS,. Fibroblast growth factor receptor expression reflects cellular differentiation in human oral squamous carcinoma cell lines. Carcinogenesis 1998; 19: 1153-1156.
9. Vairaktaris E, Ragos V, Yapijakis C, et al. FGFR-2 and -3 play an important role in initial stages of oral oncogenesis. Anticancer Res 2006; 26: 4217-4221.
10. Henson BJ, Gollin SM,. Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenet Genome Res 2010; 128: 192-198.
11. Liu Z, Hartman YE, Warram JM, et al. Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells. Mol Cancer Res 2011; 9: 1008-1017.
12. Rosenthal EL, Shreenivas S, Peters GE, Grizzle WE, Desmond R, Gladson CL,. Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma. Laryngoscope 2003; 113: 1406-1410.
13. Knights V, Cook SJ,. De-regulated FGF receptors as therapeutic targets in cancer. Pharmacol Ther 2010; 125: 105-117.
14. Jeffers M, LaRochelle WJ, Lichenstein HS,. Fibroblast growth factors in cancer: therapeutic possibilities. Expert Opin Ther Targets 2002; 6: 469-482.
15. Korc M, Friesel RE,. The role of fibroblast growth factors in tumor growth. Curr Cancer Drug Targets 2009; 9: 639-651.